MRI Screening for Breast Cancer in Women at High Risk; is the Australian Breast MRI Screening Access Program Addressing the Needs of Women at High Risk of Breast Cancer?

Overview

Journal J Med Radiat Sci

Specialties Nuclear Medicine
Radiology

Date 2015 Oct 10

PMID 26451244

Citations 3

Authors

Tess Schenberg

Gillian Mitchell

Donna Taylor

Christobel Saunders

Affiliations

Soon will be listed here.

Abstract

Breast magnetic resonance imaging (MRI) screening of women under 50 years old at high familial risk of breast cancer was given interim funding by Medicare in 2009 on the basis that a review would be undertaken. An updated literature review has been undertaken by the Medical Services Advisory Committee but there has been no assessment of the quality of the screening or other screening outcomes. This review examines the evidence basis of breast MRI screening and how this fits within an Australian context with the purpose of informing future modifications to the provision of Medicare-funded breast MRI screening in Australia. Issues discussed will include selection of high-risk women, the options for MRI screening frequency and measuring the outcomes of screening.

Citing Articles

Use of Diagnostic Imaging Modalities in Modern Screening, Diagnostics and Management of Breast Tumours 1st Central-Eastern European Professional Consensus Statement on Breast Cancer.

Forrai G, Kovacs E, Ambrozay E, Barta M, Borbely K, Lengyel Z Pathol Oncol Res. 2022; 28:1610382.

PMID: 35755417 PMC: 9214693. DOI: 10.3389/pore.2022.1610382.

Cost-Effectiveness Analysis of Imaging Modalities for Breast Cancer Surveillance Among Mutation Carriers: A Systematic Review.

Li J, Jia Z, Zhang M, Liu G, Xing Z, Wang X Front Oncol. 2022; 11:763161.

PMID: 35083138 PMC: 8785233. DOI: 10.3389/fonc.2021.763161.

The Value of Tyrer-Cuzick Versus Gail Risk Modeling in Predicting Benefit from Screening MRI in Breast Cancer.

Sevdalis A, Deng X, Bandyopadhyay D, McGuire K Eur J Breast Health. 2022; 18(1):79-84.

PMID: 35059595 PMC: 8734526. DOI: 10.4274/ejbh.galenos.2021.2021-8-2.

References

Lee J, McMahon P, Kong C, Kopans D, Ryan P, Ozanne E . Cost-effectiveness of breast MR imaging and screen-film mammography for screening BRCA1 gene mutation carriers. Radiology. 2010; 254(3):793-800. PMC: 2826703. DOI: 10.1148/radiol.09091086. View

Howell S, Searle C, Goode V, Gardener T, Linton K, Cowan R . The UK national breast cancer screening programme for survivors of Hodgkin lymphoma detects breast cancer at an early stage. Br J Cancer. 2009; 101(4):582-8. PMC: 2736813. DOI: 10.1038/sj.bjc.6605215. View

Chiarelli A, Prummel M, Muradali D, Majpruz V, Horgan M, Carroll J . Effectiveness of screening with annual magnetic resonance imaging and mammography: results of the initial screen from the ontario high risk breast screening program. J Clin Oncol. 2014; 32(21):2224-30. DOI: 10.1200/JCO.2013.52.8331. View

Brodersen J, Siersma V . Long-term psychosocial consequences of false-positive screening mammography. Ann Fam Med. 2013; 11(2):106-15. PMC: 3601385. DOI: 10.1370/afm.1466. View

Lehman C, Gatsonis C, Kuhl C, Hendrick R, Pisano E, Hanna L . MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med. 2007; 356(13):1295-303. DOI: 10.1056/NEJMoa065447. View

Lee C, Cevik M, Alagoz O, Sprague B, Tosteson A, Miglioretti D . Comparative effectiveness of combined digital mammography and tomosynthesis screening for women with dense breasts. Radiology. 2014; 274(3):772-80. PMC: 4455673. DOI: 10.1148/radiol.14141237. View

Warner E, Hill K, Causer P, Plewes D, Jong R, Yaffe M . Prospective study of breast cancer incidence in women with a BRCA1 or BRCA2 mutation under surveillance with and without magnetic resonance imaging. J Clin Oncol. 2011; 29(13):1664-9. PMC: 4874196. DOI: 10.1200/JCO.2009.27.0835. View

Ottesen G, Graversen H, Blichert-Toft M, Zedeler K, Andersen J . Lobular carcinoma in situ of the female breast. Short-term results of a prospective nationwide study. The Danish Breast Cancer Cooperative Group. Am J Surg Pathol. 1993; 17(1):14-21. DOI: 10.1097/00000478-199301000-00002. View

Amir E, Freedman O, Seruga B, Evans D . Assessing women at high risk of breast cancer: a review of risk assessment models. J Natl Cancer Inst. 2010; 102(10):680-91. DOI: 10.1093/jnci/djq088. View

10.

Cummings S, Tice J, Bauer S, Browner W, Cuzick J, Ziv E . Prevention of breast cancer in postmenopausal women: approaches to estimating and reducing risk. J Natl Cancer Inst. 2009; 101(6):384-98. PMC: 2720698. DOI: 10.1093/jnci/djp018. View

11.

Brewer N, Salz T, Lillie S . Systematic review: the long-term effects of false-positive mammograms. Ann Intern Med. 2007; 146(7):502-10. DOI: 10.7326/0003-4819-146-7-200704030-00006. View

12.

Hartmann L, Degnim A, Santen R, Dupont W, Ghosh K . Atypical hyperplasia of the breast--risk assessment and management options. N Engl J Med. 2015; 372(1):78-89. PMC: 4347900. DOI: 10.1056/NEJMsr1407164. View

13.

Kriege M, Brekelmans C, Boetes C, Besnard P, Zonderland H, Obdeijn I . Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med. 2004; 351(5):427-37. DOI: 10.1056/NEJMoa031759. View

14.

Riedl C, Luft N, Bernhart C, Weber M, Bernathova M, Tea M . Triple-modality screening trial for familial breast cancer underlines the importance of magnetic resonance imaging and questions the role of mammography and ultrasound regardless of patient mutation status, age, and breast density. J Clin Oncol. 2015; 33(10):1128-35. PMC: 5526626. DOI: 10.1200/JCO.2014.56.8626. View

15.

Sprague B, Stout N, Schechter C, van Ravesteyn N, Cevik M, Alagoz O . Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts. Ann Intern Med. 2014; 162(3):157-66. PMC: 4314343. DOI: 10.7326/M14-0692. View

16.

Phi X, Houssami N, Obdeijn I, Warner E, Sardanelli F, Leach M . Magnetic resonance imaging improves breast screening sensitivity in BRCA mutation carriers age ≥ 50 years: evidence from an individual patient data meta-analysis. J Clin Oncol. 2014; 33(4):349-56. DOI: 10.1200/JCO.2014.56.6232. View

17.

Gail M, Brinton L, Byar D, Corle D, Green S, Schairer C . Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989; 81(24):1879-86. DOI: 10.1093/jnci/81.24.1879. View

18.

Warner E, Plewes D, Hill K, Causer P, Zubovits J, Jong R . Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA. 2004; 292(11):1317-25. DOI: 10.1001/jama.292.11.1317. View

19.

Kuhl C, Schrading S, Leutner C, Morakkabati-Spitz N, Wardelmann E, Fimmers R . Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol. 2005; 23(33):8469-76. DOI: 10.1200/JCO.2004.00.4960. View

20.

Leach M, Boggis C, Dixon A, Easton D, Eeles R, Evans D . Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet. 2005; 365(9473):1769-78. DOI: 10.1016/S0140-6736(05)66481-1. View